LCM
LONA

Lynx1 Capital Management’s LeonaBio Inc LONA Stock Holding History

Lynx1 Capital Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,357
Closed -$571K – 19
2023
Q2 		$571K Buy
+19,357
New +$551K 0.37% 15

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lynx1 Capital Management's LONA Position: Q3 2023 in Review

Lynx1 Capital Management sold out of LeonaBio Inc (LONA) in Q3 2023, closing a stake of 19,357 shares — an estimated $571K sold.

Lynx1 Capital Management first reported a position in LONA in Q2 2023 and held it in 1 quarter. The position peaked at $571K in Q2 2023. 70 funds tracked by Wall St. Rank hold LONA as of Q3 2023.

  • Lynx1 Capital Management reported no remaining LeonaBio Inc position as of Q3 2023 after selling out during the quarter.
  • Lynx1 Capital Management sold 19,357 LeonaBio Inc shares in Q3 2023, an estimated $571K.
  • Lynx1 Capital Management first reported a position in LeonaBio Inc in Q2 2023 and held it in 1 quarter.
  • Lynx1 Capital Management's LeonaBio Inc position peaked at $571K in Q2 2023.
  • 70 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2023.

Based on Lynx1 Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.